PMID- 38318092 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240207 IS - 2288-6575 (Print) IS - 2288-6796 (Electronic) IS - 2288-6575 (Linking) VI - 106 IP - 2 DP - 2024 Feb TI - Risk factors for incisional hernia after liver transplantation in the era of mammalian target of rapamycin inhibitors use: a retrospective study of living donor liver transplantation dominant center in Korea. PG - 115-123 LID - 10.4174/astr.2024.106.2.115 [doi] AB - PURPOSE: Incisional hernia (IH) is a common complication after liver transplantation (LT) with an incidence rate of 5% to 46%. This retrospective study aimed to evaluate the risk factors for IH development after LT in the era of mammalian target of rapamycin (mTOR) inhibitors use. METHODS: Data on patients who underwent LT between 2015 and 2021 were retrospectively reviewed. The patients were divided into 2 groups (IH group and non-IH group) according to the postoperative occurrence of IH. RESULTS: We analyzed data from 878 patients during the study period, with 28 patients (3.2%) developing IH. According to multivariate analysis, body mass index exceeding 25 kg/m(2) and the use of mTOR inhibitors within the first month after LT were the sole significant factors for both IH occurrence and the subsequent need for repair operations. Notably, a history of wound complications, a Model for End-stage Liver Disease score, and the timing of LT-whether conducted during regular hours or at night-did not emerge as significant risk factors for IH after LT. CONCLUSION: Our study reveals a higher incidence of IH among obese patients following LT, often requiring surgical repair, particularly in cases involving mTOR inhibitor usage within the initial month after LT. Consequently, it is crucial to exercise increased vigilance, especially in obese patients, and exercise caution when considering early mTOR inhibitor administration after LT. CI - Copyright (c) 2024, the Korean Surgical Society. FAU - Kim, Jae-Yoon AU - Kim JY AUID- ORCID: 0000-0002-2546-3752 AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. FAU - Hong, Suk Kyun AU - Hong SK AUID- ORCID: 0000-0002-0020-6215 AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. FAU - Kim, Jiyoung AU - Kim J AUID- ORCID: 0000-0001-7464-8836 AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. FAU - Choi, Hyun Hwa AU - Choi HH AUID- ORCID: 0000-0003-1476-5410 AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. FAU - Lee, Jaewon AU - Lee J AUID- ORCID: 0000-0002-0248-5553 AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. FAU - Hong, Su Young AU - Hong SY AUID- ORCID: 0000-0002-9934-0456 AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. FAU - Lee, Jeong-Moo AU - Lee JM AUID- ORCID: 0000-0001-7806-8759 AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. FAU - Choi, YoungRok AU - Choi Y AUID- ORCID: 0000-0003-2408-7086 AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. FAU - Yi, Nam-Joon AU - Yi NJ AUID- ORCID: 0000-0002-5467-425X AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. FAU - Lee, Kwang-Woong AU - Lee KW AUID- ORCID: 0000-0001-6412-1926 AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. FAU - Suh, Kyung-Suk AU - Suh KS AUID- ORCID: 0000-0002-9535-7349 AD - Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. LA - eng PT - Journal Article DEP - 20240129 PL - Korea (South) TA - Ann Surg Treat Res JT - Annals of surgical treatment and research JID - 101622895 PMC - PMC10838656 OTO - NOTNLM OT - Incisional hernia OT - Liver transplantation OT - mTOR inhibitors COIS- Conflict of Interest: No potential conflict of interest relevant to this article was reported. EDAT- 2024/02/06 06:43 MHDA- 2024/02/06 06:44 PMCR- 2024/02/01 CRDT- 2024/02/06 03:51 PHST- 2023/08/24 00:00 [received] PHST- 2023/10/31 00:00 [revised] PHST- 2023/11/26 00:00 [accepted] PHST- 2024/02/06 06:44 [medline] PHST- 2024/02/06 06:43 [pubmed] PHST- 2024/02/06 03:51 [entrez] PHST- 2024/02/01 00:00 [pmc-release] AID - 10.4174/astr.2024.106.2.115 [doi] PST - ppublish SO - Ann Surg Treat Res. 2024 Feb;106(2):115-123. doi: 10.4174/astr.2024.106.2.115. Epub 2024 Jan 29.